Researchers at the University of Seville have carried out a study to determine the relationship between prenatal and early ...

As Dr. Christopher Bellavita observed in his 2008 article "Changing Homeland Security: What is Homeland Security?", "The ...

Adaptive Biotechnologies (NASDAQ:ADPT) used a presentation at the J.P. Morgan healthcare conference to outline growth drivers ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...

Restricted access to genome-editing technologies poses serious challenges for countries like India that urgently need such ...

An immunologist imagines the body’s defense system as a team of unique, quirky characters, showcasing their essential roles.

ABSTRACT: Repeated exposure to cruciferous allyl nitrile can induce antioxidant and phase 2 detoxification enzymes in various tissues. In the present study, we examined the effect of five days ...

Dec 15 (Reuters) - Adaptive Biotechnologies (ADPT.O), opens new tab said on Monday it has signed two non-exclusive deals with Pfizer (PFE.N), opens new tab to support research in rheumatoid arthritis ...

SEATTLE, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s ...

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral replication but rarely achieving functional cure. Adaptive immunity is ...

Lung cancer remains the leading cause of cancer-related mortality globally, with metastasis and recurrence as the primary determinants of poor prognosis. Despite advances in immunotherapy, intrinsic ...